France· FR:65959832
DOPACEPTIN 5 mg/ml, solution pour perfusion
A medicinal product containing chlorhydrate d'apomorphine hémihydraté, registered in France by EVER NEURO PHARMA (AUTRICHE), on the national reimbursement list.
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- CHLORHYDRATE D'APOMORPHINE HÉMIHYDRATÉ
- Manufacturer
- EVER NEURO PHARMA (AUTRICHE)
- Country
- France (FR)
- ATC code
- —
- Reimbursed
- Yes
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 1
1 priced- cip1334009278187525 flacon(s) en verre de 20 mlEUR 88.72
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Chlorhydrate d'apomorphine hémihydraté in 14 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- NetherlandsAPO-go 5 mg/ml, oplossing voor infusie in een voorgevulde spuitStada Arzneimittel AG
- IrelandAPO-go POD 5 mg/ml solution for infusion in cartridgeStada Arzneimittel AG
- CzechiaBRITAJECTSTADA Arzneimittel AG, Bad Vilbel
- FinlandApogo PenParanova Oy
- United KingdomAPO-go 20mg/2ml solution for injection ampoulesBritannia Pharmaceuticals Ltd
- SpainAPO-GO 10 mg/ml SOLUCIÓN INYECTABLE O PARA PERFUSIÓN EN AMPOLLASStada Arzneimittel Ag
- SwedenAPO-go 10 mg/ml Injektions-/infusionsvätska, lösningSTADA Arzneimittel AG
- SwitzerlandAPO-go
Authorised across Europe · EMA
The same active substance is authorised in 28 EEA countries. Names it is sold under:
- Austria · Apo-Go, Apo-Go Ampullen
- Belgium · Apo-Go ®-Cartridge, Apo-Go-Pen
- Bulgaria · Dacepton, Апо-Гo Пнс
- Cyprus · Apo-Go Pfs, Apo-Go Συσκευή Τύπου Πένασ
- Czechia · Britaject, Britaject Pen
- Germany · Apo-Go, Apo-Go Ampullen
- Denmark · Apo-Go Pen, Apo-Go Pod
- Estonia · Apo-Go, Dacepton
- Spain · Apo-Go, Apo-Go Pen
- Finland · Apogo Pen, Dacepton
- United Kingdom (Northern Ireland) · Apo-Go Ampoules, Apo-Go Pen
- Greece · Apo-Go Pfs, Apo-Go Pod
- Croatia · Dacepton
- Hungary · Dacepton
- Ireland · Apo-Go Ampoules, Apo-Go Pen
- Italy · Apofin, Dacepton
- Lithuania · Britaject, Dacepton
- Luxembourg · Apo-Go Ampoules, Apo-Go Pen
- Latvia · Apo-Go, Apo-Go Pen
- Malta · Apo-Go Pen, Apo-Go Pfs
- Netherlands · Apo-Go, Apo-Go Ampullen
- Norway · Apomorfin Pharmswed, Britaject
- Poland · Dacepton
- Portugal · Apo-Go, Apo-Go Pen
- Romania · Apo-Go
- Sweden · Apo-Go, Apo-Go För Pod
- Slovenia · Apo-Go, Dacepton
- Slovakia · Dacepton
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/c9894cee-2f8d-44f4-9efb-fbfd3ce4d8bf GET /v1/drugs/c9894cee-2f8d-44f4-9efb-fbfd3ce4d8bf?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "65959832",
"date_amm": "2014-03-20",
"type_amm": "Procédure décentralisée",
"numero_ue": null,
"substance": "CHLORHYDRATE D'APOMORPHINE HÉMIHYDRATÉ",
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "solution pour perfusion",
"voies_administration": "sous-cutanée",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Non"
}See everything about chlorhydrate d'apomorphine hémihydraté.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.